|
| Issue Date | Title | Author(s) |
| 16-Feb-2024 | Curcumin-Loaded Nanoparticles in Neurodegenerative Diseases | Youshia, John ; Gabal, Yasmine M.; Mansour, Mai ; Gad, Heba A. |
| 30-May-2020 | Delineating penetration enhancer-enriched liquid crystalline nanostructures as novel platforms for improved ophthalmic delivery | El-Gendy, Mohamed A.; El-Assal, Mona I.A.; Aziz Ishak, Rania ; Mortada, Nahed D. ; Mansour, Mai |
| Feb-2021 | Delineating the usage of dexamethasone-loaded cubosomes as a therapeutic armamentarium for hearing loss versus its protective effect: In-vitro and in-vivo animal study | Mansour, Mai |
| Mar-2021 | Intranasal versus intraperitoneal Myrj 59-stabilized cubosomes: A potential armamentarium of effective anti-diabetic therapy | Mansour, Mai |
| Mar-2021 | Investigating the Internalization and COVID-19 Antiviral Computational Analysis of Optimized Nanoscale Zinc Oxide | Mansour, Mai |
| Dec-2021 | Novel Approaches of Solid Lipid Nanoparticles as Drug Carrier | Mansour, Mai ; Hathout, Rania M |
| Aug-2017 | Novel polyglycerol-dioleate based cubosomal dispersion with tailored physical characteristics for controlled delivery of ondansetron | Mansour, Mai ; Nahed Mortada |
| Sep-2008 | Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels | Mansour, Mai ; Nahed Mortada |
| Aug-2022 | “Plurol will not miss the boat”: A new manifesto of galantamine conveyance. | Mansour, Mai |
| 20-Jul-2024 | Tailored green synthesized silymarin-selenium nanoparticles: Topical nanocarrier of promising antileishmanial activity | Mahmoud Abd-Alaziz, Dina; Mansour, Mai ; Nasr, Maha ; Sammour, Omaima |
| 20-Jul-2024 | Tailored green synthesized silymarin-selenium nanoparticles: Topical nanocarrier of promising antileishmanial activity | Mahmoud Abd-Alaziz, Dina; Mansour, Mai ; Nasr, Maha ; Sammour, Omaima |
